Bharat Biotech had agreed to offer vaccine at reasonable rates to Govt: MoH

ICMR has spent Rs 35 cr on Covaxin clinical trials

Covaxin maker Bharat Biotech India (BBIL) had agreed to provide the vaccine at a ‘reasonable and negotiated’ price to the Indian Council of Medical Research (ICMR) as well as all Central and state government bodies, minister of state for health revealed in the Parliament.

Responding to a query in the Rajya Sabha, Bharti Pravin Pawar, minister of state, Health and Family Welfare, said: “BBIL had agreed to provide vaccine at a reasonable and negotiated price to ICMR as well as all Central and State Government bodies or affiliates etc as and when the vaccine is available for use.”

BBIL had said in